IL-4 Prevents Insulitis and Insulin-Dependent Diabetes Mellitus in Nonobese Diabetic Mice by Potentiation of Regulatory T Helper-2 Cell Function

Journal of Immunology

Volumn 159, Issue 10, 1997, Pages 4686-4692

  Cameron, Mark J ^a,b   Arreaza, Guillermo A ^a   Zucker, Peter ^a   Chensue, Stephen W ^c   Strieter, Robert M ^d   Chakrabarti, Subrata ^b   Delovitch, Terry L ^a,b  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c UNIVERSITY OF MICHIGAN   (United States)

^d UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HERMES ANTIGEN; IMMUNOGLOBULIN E; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 4;

ANIMAL; ARTICLE; BIOSYNTHESIS; BLOOD; CD4+ T LYMPHOCYTE; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; FEMALE; IMMUNOLOGY; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; INTRAPERITONEAL DRUG ADMINISTRATION; LONGITUDINAL STUDY; METABOLISM; MOUSE; MOUSE MUTANT; NONOBESE DIABETIC MOUSE; PANCREAS; PANCREAS ISLET; PATHOLOGY; SIALOADENITIS; SPLEEN; TH2 CELL; THYMUS; THYROIDITIS; TIME;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGENS, CD44; CD4-POSITIVE T-LYMPHOCYTES; DIABETES MELLITUS, TYPE 1; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FEMALE; IMMUNOGLOBULIN E; INCIDENCE; INJECTIONS, INTRAPERITONEAL; INTERLEUKIN-4; ISLETS OF LANGERHANS; LONGITUDINAL STUDIES; MICE; MICE, INBRED NOD; MICE, SCID; PANCREAS; SIALADENITIS; SPLEEN; TH2 CELLS; THYMUS GLAND; THYROIDITIS; TIME FACTORS;

EID: 0031573072     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Bach, J. F. 1994. Insulin-dependent diabetes mellitus as an autoimmune disease. Endocr. Rev. 15:516.
2. Atkinson, M. A., and N. K. Maclaren. 1994. Mechanisms of disease: the pathosenesis of insulin-dependent diabetes mellitus. N. Engl. J. Med. 331:1428.
3. Tisch, R., and H. O. McDevitt. 1996. Insulin-dependent diabetes mellitus. Cell 85:291.
4. + T cells from diabetic versus prediabetic NOD. NON-Thy-1a donors. Diabetes 42:44.
5. + T cells. J. Exp. Med. 166:821.
6. Rohane, P. W., A. Shimada, D. T. Kim, C. T. Edwards, B. Charlton, L. D. Shultz, and C. G. Fathman. 1995. Islet-infiltrating lymphocytes from prediabetic NOD mice rapidly transfer diabetes to NOD-scid/scid mice. Diabetes 44:550.
7. + T cells in the destruction of islet grafts by spontaneously diabetic mice. Proc. Natl. Acad. Sci. USA 88:527.
8. + islet specific T cell clone. Science 249:1433.
9. + T cells. Annu. Rev. Immunol. 12:635.
10. + T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol. Today 16: 34.
11. Rabinovitch, A. 1994. Immunoregulatory and cytokine imbalances in the pathosenesis of IDDM: therapeutic intervention by immunostimulation? Diabetes 43: 613.
12. Katz, J. D., C. Benoist, and D. Mathis. 1995. T helper cell subsets in insulin-dependent diabetes. Science 268:1185.
13. Rocken, M. R., M. Racke, and E. M. Schevach. 1996. IL-4-induced immune deviation as antigen-specific therapy for inflammatory autoimmune disease. Immunol. Today 17:225.
14. Zipris, D., A. H. Lazarus, A. R. Crow, M. Hadzija, and T. L. Delovitch. 1991. Defective thymic T cell activation by concanavalin A and anti-CD3 in autoimmune nonobese diabetic mice. J. Immunol. 146:3763.
15. Rapoport, M. J., A. Jaramillo, D. Zipris, A. H. Lazarus, D. V. Serreze, E. H. Leiter, P. Cyopick, J. S. Danska, and T. L. Delovitch. 1993. Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J. Exp. Med. 178:87.
16. Berman, M. A., C. I. Sandborg, Z. Wang, K. L. Imfeld, F. Zaldivar, V. Dadufalza, and B. A. Buckingham. 1996. Decreased IL-4 production in new onset type I insulin-dependent diabetes mellitus. J. Immunol. 157:4691.
17. Mueller, R., T. Krahl, and N. Sarvetnick. 1996. Pancreatic expression of inter leukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice. J. Exp. Med. 184:1093.
18. Jaramillo, A., B. M. Gill, and T. L. Delovitch. 1994. Insulin-dependent diabetes mellitus in the non-obese diabetic mouse: a disease mediated by T cell anergy? Life Sci. 55:1163.
19. +-like thymocytes in the NOD mouse. Eur. J. Immunol. 26:2989.
20. Arreaza, G. A., M. J. Cameron, and T. L. Delovitch. 1996. Interleukin-4: potential immunoregulatory agent in therapy of insulin-dependent diabetes mellitus. Clin. Immunother. 4:251.
21. Lukacs, N. W., S. L. Kunkel, R. M. Strieter, K. Warmington, and S. W. Chensue. 1993. The role of macrophage inflammatory protein 1α in Schistosoma mansoni egg-induced granulomatous inflammation. J. Exp. Med. 177:1551.
22. Ryan, J. J. 1997. Interleukin-4 and its receptor: essential mediators of the allergic response. J. Allergy Clin. Immunol. 99:1.
23. Haynes, B., M. J. Telen, L. P. Hale, and S. M. Denning. 1989. CD44: a molecule involved in leukocyte adherence and T cell activation. Immunol. Today 10:423.
24. Aruffo, A. 1996. CD44: one ligand, two functions. J. Clin. Invest. 98:2191.
25. McKee, C. M., M. B. Penno, M. Cowman, M. D. Burdick, R. M. Strieter, C. Bao, and P. W. Noble. 1996. Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages: the role of HA size and CD44. J. Clin. Invest. 98:2403.
26. Faveeuw, C., M. C. Gagnerault, and F. Lepault. 1994. Expression of homing and adhesion molecules in infiltrated islets of Langerhans and salivary glands of nonobese diabetic mice. J. Immunol. 152:5969.
27. Milde, K. F., M. Alonso, S. S. Kong, R. Alejandro, D. H. Mintz, and R. L. Pastori. 1996. Expression of a specific subset of CD44 variant transcripts in NOD pancreatic islets. Diabetes 45:718.
28. Mikecz, K., F. R. Brennan, J. H. Kim, and T. T. Glant. 1995. Anti-CD44 treatment abrogates tissue oedema and leukocyte infiltration in murine arthritis. Nat. Med. 1:558.
29. Fox, C. J., and J. S. Danska. 1997. IL-4 expression at the onset of islet inflammation predicts nondestructive insulitis in nonobese diabetic mice. J. Immunol. 158:2414.
30. Perez, V. L., J. A. Lederer, A. H. Lichtman, and A. K. Abbas. 1995. Stability of Th1 and Th2 populations. Int. Immunol. 7:869.
31. Szabo, S. J., N. G. Jacobson, A. S. Dighe, U. Gubler, and K. M. Murphy. 1995. Developmental commitment to the Th2 lineage by extinction of IL-12 signaling. Immunity 2:665.
32. Szabo, S. J., A. S. Dighe, U. Gubler, and K. M. Murphy. 1997. Regulation of the interleukin (IL)-12R β2 subunit expression in developing T helper 1 (Th1) and Th2 Cells. J. Exp. Med. 185:817.
33. Murphy, E., K. Shibuya, N. Hosken, P. Openshaw, V. Maino, K. Davis, K. Murphy, and A. O'Garra. 1996. Reversibility of T helper 1 and 2 populations is lost after long term stimulation. J. Exp. Med. 183:901.
34. Yoshimoto, K., S. L. Swain, and L. M. Bradley. 1996. Enhanced development of Th2-like primary CD4 effectors in response to sustained exposure to limited rlL-4 in vivo. J. Immunol. 156:3267.
35. Pilstrom, B., L. Bjork, and J. Bohme. 1995. Demonstration of a Th1 cytokine profile in the late phase of NOD insulitis. Cytokine 7:806.
36. Herold, K. C., V. Vezys, Q. Sun, D. Viktora, E. Seung, S. Reiner, and D. R. Brown. 1996. Regulation of cytokine production during development of autoimmune diabetes induced with multiple low doses of streptozotocin. J. Immunol. 156:3521.
37. Rabinovitch, A., W. Suarez, O. Sorensen, C. Bleackley, and R. F. Power. 1995. IFN-γ gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetic mice. J. Immunol. 154:4874.
38. Shehadeh, N. N., F. LaRosa, and K. J. Lafferty. 1993. Altered cytokine activity in adjuvant inhibition of autoimmune diabetes. J. Autoimmun. 6:291.
39. von Herrath, M. G., and M. B. A. Oldstone. 1997. Interferon-γ is essential for destruction of β cells and development of IDDM. J. Exp. Med. 185:531.
40. Rocken, M. R., M. Racke, and E. M. Shevach. 1996. IL-4-induced immune deviation as antigen-specific therapy for inflammatory autoimmune disease. Immunol. Today 17:225.
41. Scott, B., R. Liblau, S. Degermann, L. A. Marconi, L. Ogata, A. J. Caton, H. O. McDevitt, and D. Lo. 1994. A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity. Immunity 1:73.
42. + TC1 cells: loss of IL-2 synthesis and autonomous proliferation but retention of cytotoxicity and synthesis of other cytokines. J. Exp. Med. 182:1505.
43. + T cells in recovery from antigen-induced autoimmune disease. J. Exp. Med. 178:909.
44. Swain, S. L. 1994. Generation and in vivo persistence of polarized Th1 and Th2 memory cells. Immunity 1:543.